Flagship Pioneering’s newest startup is Expedition Medicines, a company whose artificial intelligence-driven technology platform analyzes the human proteome to learn the chemistry of binding small molecules to protein targets long considered “undruggable.” Expedition already has a cancer drug R&D alliance with Pfizer.
The post Startup Expedition Medicines Launches to Learn Nature’s Rules for Binding Elusive Proteins appeared first on MedCity News.
